Indeed, treatment of mice bearing PyMT1/GPx2 KD tumors with daily intraperitoneal injection of echinomycin for 21 d following tumor onset substantially reduced mammary tumor growth (Fig. 3G). Here, GPX2 is linked to neoplasm.